ArticleDiscover oncology2026
LAMP2 drives M2 macrophage polarization and promotes glioma progression through autophagy.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Macrophages are abundant immune cells in the glioma microenvironment and are closely associated with cancer progression. Lysosome-associated membrane protein 2 (LAMP2) is a key regulator involved in the maturation of autophagolysosomes. This study employed scRNA-seq and bulk RNA-seq analyses to identify the potential role of LAMP2 in low-grade glioma (LGG) progression. In glioma cells, LAMP2 was upregulated, and lentiviral knockdown of LAMP2 significantly inhibited cell proliferation, migration and invasion, while increasing apoptosis. In vivo, LAMP2 knockdown suppressed tumor growth. Mechanistically, in glioma cells, LAMP2 silencing reduced autolysosome formation and impaired late-stage autophagic flux, supporting a role for LAMP2 in autophagolysosome maturation. In macrophages, LAMP2 expression was higher in M2-polarized cells, and LAMP2 overexpression enhanced M2 markers together with autophagic activity; autophagy inhibition by 3-MA attenuated these effects. Importantly, conditioned medium from LAMP2-overexpressing M2 macrophages promoted malignant phenotypes of glioma cells, supporting a macrophage-to-tumor pro-tumor effect. These findings highlight LAMP2 as a critical regulator of autophagy-mediated macrophage polarization and tumor progression, suggesting its potential as a prognostic biomarker and therapeutic target in LGG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.